Suicide Plus Immune Gene Therapy for Advanced Melanoma
Clinical trial NCT03338777 · TERMINATED
Trial details
- NCT number
- NCT03338777
- Sponsor
- Hospital Italiano de Buenos Aires
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-20
- Primary completion
- 2020-02-20
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.